Hospital Israelita Albert Einstein
Clinical trials sponsored by Hospital Israelita Albert Einstein, explained in plain language.
-
New hope for sickle cell: High-Dose drug may boost stem cell harvest
Disease control Not yet recruitingThis study tests whether a high dose of plerixafor can safely collect enough stem cells from people with sickle cell disease for a future transplant. About 12 participants aged 18-25 will receive transfusions, take the drug, and have stem cells collected through a process called …
Phase: PHASE1, PHASE2 • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Can a text message improve your ER Follow-Up?
Knowledge-focused Not yet recruitingThis study looks at different ways to contact patients after they leave the emergency room. Currently, patients get a phone call. The researchers want to see if adding text reminders and emails helps patients connect faster. About 466 adults who are low-risk will take part.
Phase: NA • Sponsor: Hospital Israelita Albert Einstein • Aim: Knowledge-focused
Last updated May 26, 2026 04:45 UTC
-
New registry to uncover sepsis outcomes
Knowledge-focused Not yet recruitingThis study is a registry that will follow 760 adults hospitalized with sepsis to learn how they are treated in the hospital and how they recover after discharge. Researchers will track deaths and major health events like heart attacks or strokes for up to a year. The goal is to b…
Sponsor: Hospital Israelita Albert Einstein • Aim: Knowledge-focused
Last updated May 26, 2026 04:31 UTC